← Open Payments lookup

RUSTI HAUGE: Open Payments

NPI 1639124092 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$354 in 15 payments from 10 companies in 2025. Trend: 2023 $421 · 2024 $518 · 2025 $354

Food & beverage: $354
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$92
Takeda Pharmaceuticals U.S.A., Inc.2$48
ABBVIE INC.2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Otsuka America Pharmaceutical, Inc.1$31
E.R. Squibb & Sons, L.L.C.1$27
Alkermes, Inc.1$25
Axsome Therapeutics, Inc.1$21
Supernus Pharmaceuticals, Inc.1$18
Janssen Pharmaceuticals, Inc1$15

Products named: INGREZZA, TRINTELLIX, VRAYLAR, CAPLYTA, REXULTI, COBENFY, ARISTADA, Auvelity.

Industry payments across TX — which companies pay providers there.